Silvia de Sanjose Llongueras

Affiliate Professor, Epidemiology


MD Medicine & Surgery, University of Barcelona, 1980
MSc Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1986
PhD Epidemiology, London School of Hygiene & Tropical Medicine (UK), 1989




Dr. de Sanjose is a Medical Doctor from the University of Barcelona, Spain and PhD from the London University, UK. She is an epidemiologist working on HPV-related diseases for over 35 years. She has been employed at WHO- IARC, at the Catalan Institute of Oncology in Barcelona, Spain, at PATH in Seattle, and at the USA National Cancer Institute. She is the Past President of the International PapillomaVirus Society (2015-18). She is an associated researcher at ISGlobal in Barcelona, Spain and has a grant with Dr Margaret Madeline and Ann Durr from the Fred Hutch.

She is interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. She co-leads a Moonshoot-related project, the PAVE project, which primarily emphasizes the utilization of HPV detection through self-sampling, extended genotype information, and, for women who test positive for HPV, the automated evaluation of cervical images using AI-based solutions to enhance visual assessment with acetic acid. She is involved in shaping the World Health Organization's living guidelines for cervical cancer screening and the Code of Cancer Prevention for Europe.

Research Areas

Research Interests

I am interested in the pathways of cervical cancer prevention and all HPV-related cancers through vaccination and secondary prevention and adequate management. In particular I am involved in improving cervical cancer screening in poor resource settings.

Recent Publications (PubMed)

Meeting report: Considerations for trial design and endpoints in licensing therapeutic HPV16/18 vaccines to prevent cervical cancer.
(2024 Jul 13)
Dull PM, Achilles SL, Ahmed R, Barnabas RV, Campos NG, Chirgwin K, Cohen JA, de Sanjosé S, Doorbar J, Einstein MH, Emerson CI, Gottlieb SL, Hildesheim A, Qiao Y, Ruff P, Sampson JN, Sasieni P, Schiffman M, Shin H, Stanley MA, Trimble CL, Wentzensen N, Riemer AB, Schiller JT, Kreimer AR

Proof of Concept Study: Comparability of Microbiome Diversity in Self- and Physician-Collected HPV-Positive and HPV-Negative Cervicovaginal Samples.
(2024 May 24)
Int J Mol Sci 25(11):
Asensio-Puig L, de Andrés-Pablo Á, Khannous-Lleiffe O, Ibáñez R, Acera A, de Sanjosé S, Gabaldón T, Alemany L, Bruni L, Pavón MÀ

Impact of the COVID-19 pandemic on cervical cancer screening participation, abnormal cytology prevalence and screening interval in Catalonia.
Front Oncol 14(): 1338859
Robles C, Monfil L, Ibáñez R, Roura E, Font R, Peremiquel-Trillas P, Brotons M, Martínez-Bueno C, de Sanjosé S, Espinàs JA, Bruni L

Response letter to "Understanding the age-related epithelial shifts at the uterine cervix and the area of risk for squamous cell cervical cancer".
(2024 Jul)
Prev Med 184(): 108005
Desai KT, Doorbar J, de Sanjose S, Schiffman M

Comparison of the ScreenFire and Xpert HPV assays for the detection of human papillomavirus and cervical precancer among women living with HIV in Malawi.
(2024 May 17)
Infect Agent Cancer 19(1): 24
Mungo C, Guliam A, Chinula L, Inturrisi F, Msowoya L, Mkochi T, Jawadu S, de Sanjosé S, Schiffman M, Tang JH, Smith JS

Show complete publication list

In the News

No news articles at this time.